Connect with us

Hi, what are you looking for?

News

Orezone Gold Corporation (ORZCF) Q4 2023 Earnings Call Transcript

Orezone Gold Corporation (OTCQX:ORZCF) Q4 2023 Earnings Conference Call March 27, 2024 11:00 AM ET

Company Participants

Patrick Downey – CEO
Peter Tam – CFO

Conference Call Participants

Kul Gill – TD Securities
Sean Fieler – Equinox Partners
Bryce Adams – CIBC
Alex Terentiew – PI Financial

Operator

Good morning. My name is Dennis, and I will be your conference operator today. At this time, I would like to welcome everyone to the Orezone Gold Corporation’s 2023 Year-End Results and 2024 Guidance Webcast and Conference Call. [Operator Instructions]

I would now like to turn the conference over to Patrick Downey, CEO, Orezone. Please go ahead.

Patrick Downey

Thank you, and welcome, everybody, to the webcast and conference call. Obviously, we will be making use of forward-looking statements in this presentation, so please read at your leisure. So a quick summary of Q4 and full year 2023 results. We finished the year very strongly. Q4, we had gold production of 33,916 ounces.

Our gold sales were 33,782 ounces at an all-in sustaining cost of $1,246 per ounce sold. And at the end of the quarter, we had cash of $19.5 million. 2023 was a very strong year, first full year of production for the company. We achieved our production and cost guidance. Production was 141,425 ounces, at an all-in sustaining cost of $1,127 per ounce sold.

Our plant operated extremely well at 11% above nameplate design. We had zero LTIs with 4.4 million hours worked for the year. And we repaid $33.8 million of senior debt, leaving us with $62.3 million outstanding at the year-end 2023. We also released a robust Phase 2 hard rock expansion during the year.

I’ll now hand over to Peter Tam, CFO, who will walk you through the financial and operating highlights.

Peter Tam

Thanks, Patrick.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Justine Koenigsberg – VP, IRNello Mainolfi –...

News

This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...

News

This article was written by Follow ONeil Trader is a former stockbroker turned full-time independent investor. He focuses on finding growth and biotech stocks...

News

Delek US Holdings, Inc. (NYSE:DK) Q3 2024 Earnings Conference Call November 6, 2024 10:00 AM ET Company Participants Robert Wright – Deputy Chief Financial...